|Palo Alto Health Sciences Names Amy Perry to Board of Directors|
|By: PR Newswire Association LLC. - 17 Aug 2017||Back to overview list
DANVILLE, Calif., Aug. 17, 2017 /PRNewswire/ -- Palo Alto Health Sciences, Inc. (PAHS), developer of the Freespira® treatment for panic attacks and panic disorder, today announced that Amy Perry, CEO of the Hospital Division and Senior Vice President of Integrated Care delivery at Atlantic Health System in New Jersey, will join its Board of Directors. Previously the President of Sinai Hospital in Baltimore, Ms. Perry has a long and distinguished career as an executive with health care delivery and hospital systems.
"We are very pleased to have Amy join our Board of Directors," commented Debra Reisenthel, PAHS President and CEO. "She is a passionate advocate for effective and evidence-based mental health treatments and her many years as a senior hospital executive adds significant expertise as we expand our partnerships with insurance companies and health systems to bring Freespira to more patients."
"Freespira offers an important new drug-free option for people suffering from debilitating panic symptoms," said Ms. Perry. "I am excited to be working with PAHS to improve the lives of patients, while at the same time helping to reduce their cost of care. Freespira is a highly effective, home-based treatment which offers payers, self-insured employers and integrated health systems an important and timely solution as we work together to improve affordability and access for our patients."
About Panic Attacks
About Palo Alto Health Sciences, Inc.
Freespira is commercially available throughout the U.S. and is currently being evaluated by Anthem and Highmark Health in regional Quality Improvement Programs to assess Freespira's impact in reducing the elevated medical costs of treating patients with panic disorder. Separate clinical studies are underway to treat adolescents, and to treat veterans with PTSD. To learn more, visit http://www.freespira.com or contact email@example.com.
SOURCE Palo Alto Health Sciences
Copyright 2017 PR Newswire Association LLC.
|Back to overview list|